Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Treatment of Keratoacanthoma With Topical Fluorouracil

Treatment of Keratoacanthoma With Topical Fluorouracil Abstract My colleagues and I recently described the successful treatment of keratoacanthoma (KA) with intralesional1,2 and topical 20% fluorouracil cream.3 The latter preparation is commercially unavailable and cumbersome to prepare. Therefore, we evaluated the use of topical 5% fluorouracil cream for the treatment of KA, and our results are described herein. Patients and Methods Patient data are shown in the Table. Rapidly growing lesions of 4 to 16 mm developed during periods of three to six weeks in 13 patients who ranged in age from 58 to 86 years. One patient had three such lesions when he was examined. All patients met the criteria for the clinical diagnosis of KA, namely, (1) rapid growth of the lesion for two to six weeks, (2) morphologic characteristics of a dome-shaped, smooth, skin-colored or erythematous nodule with a central keratin-filled crater, and (3) subsequent prompt response to topical fluorouracil therapy with at References 1. Odom RB, Goette DK: Treatment of keratoacanthomas with intralesional fluorouracil . Arch Dermatol 1978;114:1779-1783.Crossref 2. Goette DK, Odom RB: Successful treatment of keratoacanthoma with intralesional fluorouracil . J Am Acad Dermatol 1980;2:212-216.Crossref 3. Goette DK, Odom RB, Arrot J, et al: Treatment of keratoacanthomas with topical fluorouracil . Arch Dermatol 1982; 118:309-311.Crossref 4. Ebner H: Treatment of skin epitheliomas with 5-fluorouracil ointment: Influence of therapeutic design on recurrence of lesions . Dermatologica 1970;140( (suppl 1) ):42-46.Crossref 5. Midana A, Leigheb G: 5-Fluorouracil ointment in the treatment of benign and malignant skin lesions . Dermatologica 1970;140( (suppl 1) ):75-81.Crossref 6. Llombart Bosch M, Espinosa Cabanero JA: Preliminary experience with 5-fluorouracil ointment in the treatment of neoplasias and precancerous lesions of the skin . Dermatologica 1970;140( (suppl 1) ):82-89.Crossref 7. Banazzi M: Clinical and structural evaluation of the treatment of some hyperplastic and enoplastic skin diseases with 5-fluorouracil ointment . Dermatologica 1970;140( (suppl 1) ):90-96.Crossref 8. Woodridge WE, Frerichs JB: Multiple adenoid squamous cell carcinomas . Arch Dermatol 1971;104:202-206.Crossref 9. Williams AL: Topical 5FU: A new approach to skin cancer . Ann Surg 1971;173:864-871.Crossref 10. Grupper C: Treatment of keratoacanthomas by local applications of 5-fluorouracil ointment . Dermatologica 1970;140( (suppl 1) ):127-132.Crossref 11. Ebner H, Mischer P: Lokalbehandlung des Keratoacanthoms mit 5-Fluorouracil . Hautarzt 1975;26:585-588. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Treatment of Keratoacanthoma With Topical Fluorouracil

Archives of Dermatology , Volume 119 (11) – Nov 1, 1983

Loading next page...
 
/lp/american-medical-association/treatment-of-keratoacanthoma-with-topical-fluorouracil-ptJ2lDdmfh
Publisher
American Medical Association
Copyright
Copyright © 1983 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1983.01650350079022
Publisher site
See Article on Publisher Site

Abstract

Abstract My colleagues and I recently described the successful treatment of keratoacanthoma (KA) with intralesional1,2 and topical 20% fluorouracil cream.3 The latter preparation is commercially unavailable and cumbersome to prepare. Therefore, we evaluated the use of topical 5% fluorouracil cream for the treatment of KA, and our results are described herein. Patients and Methods Patient data are shown in the Table. Rapidly growing lesions of 4 to 16 mm developed during periods of three to six weeks in 13 patients who ranged in age from 58 to 86 years. One patient had three such lesions when he was examined. All patients met the criteria for the clinical diagnosis of KA, namely, (1) rapid growth of the lesion for two to six weeks, (2) morphologic characteristics of a dome-shaped, smooth, skin-colored or erythematous nodule with a central keratin-filled crater, and (3) subsequent prompt response to topical fluorouracil therapy with at References 1. Odom RB, Goette DK: Treatment of keratoacanthomas with intralesional fluorouracil . Arch Dermatol 1978;114:1779-1783.Crossref 2. Goette DK, Odom RB: Successful treatment of keratoacanthoma with intralesional fluorouracil . J Am Acad Dermatol 1980;2:212-216.Crossref 3. Goette DK, Odom RB, Arrot J, et al: Treatment of keratoacanthomas with topical fluorouracil . Arch Dermatol 1982; 118:309-311.Crossref 4. Ebner H: Treatment of skin epitheliomas with 5-fluorouracil ointment: Influence of therapeutic design on recurrence of lesions . Dermatologica 1970;140( (suppl 1) ):42-46.Crossref 5. Midana A, Leigheb G: 5-Fluorouracil ointment in the treatment of benign and malignant skin lesions . Dermatologica 1970;140( (suppl 1) ):75-81.Crossref 6. Llombart Bosch M, Espinosa Cabanero JA: Preliminary experience with 5-fluorouracil ointment in the treatment of neoplasias and precancerous lesions of the skin . Dermatologica 1970;140( (suppl 1) ):82-89.Crossref 7. Banazzi M: Clinical and structural evaluation of the treatment of some hyperplastic and enoplastic skin diseases with 5-fluorouracil ointment . Dermatologica 1970;140( (suppl 1) ):90-96.Crossref 8. Woodridge WE, Frerichs JB: Multiple adenoid squamous cell carcinomas . Arch Dermatol 1971;104:202-206.Crossref 9. Williams AL: Topical 5FU: A new approach to skin cancer . Ann Surg 1971;173:864-871.Crossref 10. Grupper C: Treatment of keratoacanthomas by local applications of 5-fluorouracil ointment . Dermatologica 1970;140( (suppl 1) ):127-132.Crossref 11. Ebner H, Mischer P: Lokalbehandlung des Keratoacanthoms mit 5-Fluorouracil . Hautarzt 1975;26:585-588.

Journal

Archives of DermatologyAmerican Medical Association

Published: Nov 1, 1983

References